R
Roon
Roon aims to replace traditional health resources like WebMD with video-based Q&A content by doctors and patients, addressing over 16,000 topics including ALS, dementia, and PCOS
About Roon
Roon is an online platform dedicated to supporting individuals and families navigating Glioblastoma, a type of brain cancer. The platform serves patients, caregivers, and medical professionals by providing a comprehensive suite of resources designed to empower and inform. Roon operates in the healthcare and patient support market, focusing specifically on Glioblastoma, a niche yet critical area of oncology. The business model revolves around offering access to a library of medically vetted video content, answers to common questions, and a welcoming community where users can share experiences and insights. Revenue is likely generated through subscriptions, partnerships with medical institutions, and possibly donations or grants. The platform's key features include high-quality, empathetic video content, a searchable database of common questions, and a community forum for real-time support. Roon's team comprises leading neuro-oncologists, neurosurgeons, psycho-oncologists, radiation oncologists, nurse practitioners, and social workers from top medical institutions, ensuring that the information provided is both accurate and compassionate.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- New York City, United States
- Employees
- 55
- Open positions
- None listed
- Dealroom signal
- 87.9/100
- Industry
- Health, Media
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Personal Health, Health and Wellness
- Business model
- SaaS
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Nov 2024 | $15M | $68M | Forerunner Ventures · Sequoia · FirstMark · TMV | ↗ |
| SEED✓Equity / VC | Aug 2022 | $7.5M | $30M | Maveron · Sequoia · FirstMark · M13 | ↗ |
Growth signals
Latest recorded traffic for Roon is 20K monthly website visits, down 20% over the last three months. Roon's team grew 31% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Roon on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Roon’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.